The inhibitory effects of sevoflurane on angiotensin II-induced, p44/42 mitogen-activated protein kinase-mediated contraction of rat aortic smooth muscle

Anesthesia and Analgesia

Volumn 101, Issue 2, 2005, Pages 315-321

  Yu, Jingui ^a   Mizumoto, Kazuhiro ^a   Tokinaga, Yasuyuki ^a   Ogawa, Koji ^a   Hatano, Yoshio ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SEVOFLURANE;

ANIMAL TISSUE; AORTA MEDIA; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASOCONSTRICTION; VASODILATATION; WESTERN BLOTTING;

EID: 22944432157     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000173210.12435.67     Document Type: Article

References (29)

1. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-72.
2. Damron DS, Nadim HS, Hong SJ, et al. Intracellular translocation of PKC isoforms in canine pulmonary artery smooth muscle cells by Ang II. Am J Physiol 1998;274:L278-88.
3. Matrougui K, Tanko LB, Loufrani L, et al. Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries. Arterioscler Thromb Vasc Biol 2001;21:1288-93.
4. 2+ mobilization in aortic smooth muscle cells from hypertensive rats: implication of cytoskeleton. Anesthesiology 2002;97:642-51.
5. 2+ mobilization in aortic smooth muscle cells from normotensive and hypertensive rats. Anesth Analg 2000;90:546-52.
6. 2+-elicited, contraction of rat aortic smooth muscle. Anesthesiology 2004;100:879-84.
7. Takahashi E, Berk BC. MAP kinases and vascular smooth muscle function. Acta Physiol Scand 1998;164:611-21.
8. Touyz RM, Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 2002;35:1001-15.
9. Kanagawa K, Sugimura K, Kuratsukuri K, et al. Norepinephrine activates P44 and P42 MAPK in human prostate stromal and smooth muscle cells but not in epithelial cells. Prostate 2003;56: 313-8.
10. Ishihata A, Tasaki K, Katano. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta. Eur J Pharmacol 2002;445:247-56.
11. Watts SW. Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD098059. J Pharmacol Exp Ther 1996;279:1541-50.
12. Puri RN, Fan YP, Rattan S. Role of pp60(c-src) and p(44/42) MAPK in ANG II-induced contraction of rat tonic gastrointestinal smooth muscles. Am J Physiol 2002;283:G390-9.
13. Matsumura F, Yamashiro S. Caldesmon. Curr Opin Cell Biol 1993;5:70-6.
14. Gerthoffer WT, Yamboliev IA, Shearer M, et al. Activation of MAP kinases and phosphorylation of caldesmon in canine co-Ionic smooth muscle. J Physiol 1996;495:597-609.
15. Yu J, Ogawa K, Tokinaga Y, Hatano Y. Sevoflurane inhibits guanosine 5′-[gamma-thio]triphosphate-stimulated, Rho/Rho-kinase-mediated contraction of isolated rat aortic smooth muscle. Anesthesiology 2003;99:646-51.
16. Yu J, Ogawa K, Tokinaga Y, et al. The vascular relaxing effects of sevoflurane and isoflurane are more important in hypertensive rats compared to normotensive rats. Can J Anaesth 2004; 51(10):979-85.
17. Alessi DR, Cuenda A, Cohen P, et al. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995;270:27489-94.
18. Dudley DT, Pang L, Decker SJ, et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995;92:7686-9.
19. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in aortic smooth muscle cells. J Biol Chem 1993;268: 7338-45.
20. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal biochem 1985;150: 76-85.
21. 2+/calmodulin-sensitive tyrosine kinase. J Biol Chem 1996;271:14169-75.
22. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1992;188:257-64.
23. Epstein AM, Throckmorton D, Brophy CM. Mitogen-activated protein kinase activation: an alternate signaling pathway for sustained vascular smooth muscle contraction. J Vasc Surg 1997; 26:327-32.
24. Griendling KK, Ushio-Fukai M, Lassegue B, et al. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997;29:366-73.
25. Mancia G, Parati G, Pomidossi G, et al. Modification of arterial baroreflexes by captopril in essential hypertension. Am J Cardiol 1982;49:1415-9.
26. Venkat Raman G, Waller DG, Warren DJ. The effect of captopril on autonomic reflexes in human hypertension. J Hypertens 1985;3(Suppl 2):S111-5.
27. Colson P, Saussine M, Seguin JR, et al. Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1992;74:805-8.
28. Pettinger WA. Anesthetics and the rennin-angiotensin aldosterone axis. Anesthesiology 1978;48:393-6.
29. Nyhan DP, Chen BB, Fehr DM, et al. Anesthesia alters pulmonary vasoregulation by angiotensin II and captopril. J Appl Physiol 1992;72:636-42.